期刊文献+

microRNA介导的基因工程病毒减毒株研究进展

Advances in research of microRNA-mediated gene engineering attenuated strain of virus
原文传递
导出
摘要 为了安全有效地进行基因治疗,需要把转染的基因限制在特定组织中表达。应用miRNA调节病毒基因表达是一个新方法。在miRNA介导的转基因表达系统中,可以将与miRNA互补的靶序列串联插入病毒基因3’非编码区域,导致在miRNA高表达细胞中抑制病毒的表达。我们总结了miRNA介导的病毒减毒株的应用。 For safe and effective gene therapy, targeted tissue-restricted transgene expression is desirable. A new system which can regulate viral gene expression by exploiting microRNA (miRNA) has recently been developed. In miRNA-mediated transgene expression systems, tandem copies of sequences perfectly complementary to the miRNA are usually incorporated into the 3'UTR of the viral gene,leading to the suppression of viral expression in cells expressing the corresponding miRNA. The aim of this review is to highlight the use of miRNA-mediated attenuated strain of virus.
出处 《国际呼吸杂志》 2014年第22期1727-1731,共5页 International Journal of Respiration
基金 国家自然科学基金资助项目(81200063、81470206) 中国博士后科学基金面上项目(2014M552701) 江苏省博士后基金资助项目(1302073c)
关键词 微RNA 基因工程 病毒 减毒株 MicroRNA Genetic engineering Virus Attenuated strain
  • 相关文献

参考文献23

  • 1Poulin KL, Lanthier RM, Smith AC, et al. Retargeting of adenovirus vectors through genetic fusion of a single-chain orsingle-domain antibody to capsid protein IX [J]. J Virol, 2010,84 : 10074-10086.
  • 2Boulaire J, Balani P, Wang S. Transcriptional targeting to brain cells:Engineering cell type-specifiepromoter containing cassettes for enhanced transgene expression[J]. Adv Drug Deliv Rev, 2009,61 : 589-602.
  • 3Yao X, Yoshioka Y, Morishige T, et al. Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis[J]. Gene Ther, 2009,16 : 1395-1404.
  • 4Jacobs F, Snoeys J, Feng Y, et al. Direct comparison of hepatocyte-specific expression cassettes followingadenoviral and nonviral hydrodynamic gene transfer[J]. Gene Ther, 2008,15:594-603.
  • 5Nemunaitis J, Tong AW, Nemunaitis M, et al. A phase I study of telomerase-specific replication competent oncolyticadenovirus (telomelysin) for various solid tumors [J]. Mol Ther, 2010,18 : 429-434.
  • 6Li JL, Liu HL, Zhang XR, et al. A phase I trial of intratumoral administration of recombinant oncolytie adenovirus overexpressing HSP70 in advanced solid tumor patients[J]. Gene Ther, 2009,16 : 376-382.
  • 7Leja J, Nilsson B, Yu D, et al. Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retainsneuroendocrine cell killing ability[J]. PLoS One, 2010, 5 : e8916.
  • 8Cawood R, Chen HH, Carroll F, et al. Use of tissue specific microRNA to control pathology of wild-type adenovirus withoutattenuation of its ability to kill cancer cells[J]. PLoS Pathog, 2009,5 : e1000440.
  • 9Sugio K, Sakurai F, Katayama K, et al. Enhanced safety profiles of the telomerase-specific replication-competent adenovirus by incorporation of normal cell-specific microRNA-targeted sequences[J]. Clin Cancer Res, 2011,17: 2807-2818.
  • 10Schaefer A, Jung K. Re: MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells[J]. Eur Urol, 2010,57 : 919.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部